Chloroacetaldehyde

Synthesis and occurrence

Hydrated chloroacetaldehyde is produced by the chlorination of aqueous vinyl chloride: :ClCH=CH2 + Cl2 + H2O → ClCH2CHO + 2 HCl It can also be prepared from vinyl acetate or by careful chlorination of acetaldehyde. The related bromoacetaldehyde is prepared via bromination of vinyl acetate. It also rapidly forms an acetals in the presence of alcohols.

Water free chloroacetaldehyde is prepared from the hydrate by azeotropic distillation with chloroform, toluene, or carbon tetrachloride. Anhydrous chloroacetaldehyde reversibly converts to polyacetals. Less reactive chloroacetaldehyde derivatives might be used instead to obtain chloroacetaldehyde or bypass its intermediate formation completely: e.g. chloroacetaldehyde dimethyl acetal (2-chloro-1,1-dimethoxyethane) hydrolyzes in acidic conditions to give chloroacetaldehyde, which may then quickly react with the other reagents instead of polymerizing.

Relevant to its occurrence in humans, it arises via the isomerization of chloroethylene oxide, a metabolite of vinyl chloride.

Reactions

Chloroacetaldehyde readily hydrates: :[[File:Chloroacetaldehyde reaction01.svg|511px]]

Being bifunctional, chloroacetaldehyde is a precursor to many heterocyclic compounds. It condenses with thiourea derivatives to give aminothiazoles. This reaction was once used in the preparation of sulfathiazole, one of the first sulfa drugs.

Environmental aspects

Chloroacetaldehyde is a metabolite in the degradation of 1,2-dichloroethane, which initially converts to chloroethanol. This metabolic pathway is topical because 1,2-dichloroethane is produced on a large scale as a precursor to vinyl chloride.

Safety

Chloroacetaldehyde is corrosive to mucous membranes. It irritates eyes, skin and respiratory tract.

Based on data collected from human studies in 1962, exposures to 45 ppm of chloroacetaldehyde were found to be disagreeable and caused conjunctival irritation to the subjects. The Occupational Safety and Health Administration established a permissible exposure limit at a ceiling of 1 ppm (3 mg/m3) for exposures to chloroacetaldehyde.

References

References

1. (1996). "The Merck index". Merck.
2. {{PGCH. 0118
3. (4 December 2014). "Chloroacetaldehyde". National Institute for Occupational Safety and Health.
4. {{IDLH. 107200. Chloroacetaldehyde
5. (2007). "Chloroacetaldehydes".
6. S. M. McElvain and D. Kundiger "Bromoacetal" Organic Syntheses 1943, volume 23, p. 8. {{doi. 10.15227/orgsyn.023.0008.
7. Keiji, T. (1992-10-30). "α-Chlorocarbonyl Compounds: Their Synthesis and Applications (Commemoration Issue Dedicated to Professor Shigeo Tanimoto On the Occasion of His Retirement)". Bulletin of the Institute for Chemical Research, Kyoto University.
8. (2011). "Endogenous versus Exogenous DNA Adducts: Their Role in Carcinogenesis, Epidemiology, and Risk Assessment". Toxicological Sciences.
9. (1996). "DNA Damage: Chemistry, Repair, and Mutagenic Potential". Regulatory Toxicology and Pharmacology.
10. Janssen, D. B.; van der Ploeg, J. R. and Pries, F., "Genetics and Biochemistry of 1,2-Dichloroethane Degradation", Biodegradation, 1994, 5, 249-57.{{doi. 10.1007/BF00696463
11. [https://www.cdc.gov/niosh/idlh/107200.html Documentation for Immediately Dangerous To Life or Health Concentrations (IDLHs)]
12. [https://www.cdc.gov/niosh/npg/npgd0118.html CDC - NIOSH Pocket Guide to Chemical Hazards]